JP2010516688A5 - - Google Patents

Download PDF

Info

Publication number
JP2010516688A5
JP2010516688A5 JP2009546483A JP2009546483A JP2010516688A5 JP 2010516688 A5 JP2010516688 A5 JP 2010516688A5 JP 2009546483 A JP2009546483 A JP 2009546483A JP 2009546483 A JP2009546483 A JP 2009546483A JP 2010516688 A5 JP2010516688 A5 JP 2010516688A5
Authority
JP
Japan
Prior art keywords
contacting
antimicrobial
bacterium
peptide
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009546483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010516688A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/051101 external-priority patent/WO2008140834A2/en
Publication of JP2010516688A publication Critical patent/JP2010516688A/ja
Publication of JP2010516688A5 publication Critical patent/JP2010516688A5/ja
Pending legal-status Critical Current

Links

JP2009546483A 2007-01-16 2008-01-15 抗菌ペプチド Pending JP2010516688A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88078307P 2007-01-16 2007-01-16
PCT/US2008/051101 WO2008140834A2 (en) 2007-01-16 2008-01-15 Novel antimicrobial peptides

Publications (2)

Publication Number Publication Date
JP2010516688A JP2010516688A (ja) 2010-05-20
JP2010516688A5 true JP2010516688A5 (cg-RX-API-DMAC10.html) 2013-05-23

Family

ID=40002852

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009546483A Pending JP2010516688A (ja) 2007-01-16 2008-01-15 抗菌ペプチド

Country Status (8)

Country Link
US (2) US7713927B2 (cg-RX-API-DMAC10.html)
EP (1) EP2118122B1 (cg-RX-API-DMAC10.html)
JP (1) JP2010516688A (cg-RX-API-DMAC10.html)
CN (1) CN101622271B (cg-RX-API-DMAC10.html)
AU (1) AU2008251748B2 (cg-RX-API-DMAC10.html)
ES (1) ES2548767T3 (cg-RX-API-DMAC10.html)
IL (1) IL199835A (cg-RX-API-DMAC10.html)
WO (1) WO2008140834A2 (cg-RX-API-DMAC10.html)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2049137A4 (en) * 2006-08-08 2013-05-01 Univ California SALICYLANILIDES AS AMPLIFIERS OF THE ORAL RELEASE OF THERAPEUTIC PEPTIDES
CA2661634C (en) 2006-09-06 2017-03-28 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
CN101622271B (zh) * 2007-01-16 2014-08-27 加利福尼亚大学董事会 抗微生物肽
EP2168976A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
US8303962B2 (en) * 2009-01-06 2012-11-06 C3 Jian, Inc. Antibacterial and antifungal peptides
US20100202983A1 (en) * 2009-02-09 2010-08-12 Jernberg Gary R Selectively targeted antimicrobials for the treatment of periodontal disease
US12279989B2 (en) 2011-02-04 2025-04-22 Seed Health, Inc. Method and system for increasing beneficial bacteria and decreasing pathogenic bacteria in the oral cavity
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US12257272B2 (en) 2015-12-24 2025-03-25 Seed Health, Inc. Method and system for reducing the likelihood of developing depression in an individual
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11998479B2 (en) 2011-02-04 2024-06-04 Seed Health, Inc. Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure
US10085938B2 (en) * 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US12533312B2 (en) 2011-02-04 2026-01-27 Seed Health, Inc. Method and system for preventing sore throat in humans
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US9987224B2 (en) * 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
WO2012154959A1 (en) * 2011-05-11 2012-11-15 Elixir Institute Of Regenerative Medicine Peptide tyrosinase inhibitors and uses thereof
US12083158B2 (en) * 2011-10-07 2024-09-10 Morehouse School Of Medicine Antibacterial compositions, methods of making and use thereof
US9028807B2 (en) 2012-04-05 2015-05-12 Ues, Inc. Synthesis models for antimicrobial agents via the halogenation of organic/inorganic composites
CN103172701B (zh) * 2013-03-18 2015-09-30 中国科学院过程工程研究所 一种新型穿膜肽及其应用
JP2014218496A (ja) * 2013-04-08 2014-11-20 和興フィルタテクノロジー株式会社 高保存性抗体溶液
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US12329783B2 (en) 2013-12-20 2025-06-17 Seed Health, Inc. Method and system to improve the health of a person's skin microbiome
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US12246043B2 (en) 2013-12-20 2025-03-11 Seed Health, Inc. Topical application to treat acne vulgaris
US11998574B2 (en) 2013-12-20 2024-06-04 Seed Health, Inc. Method and system for modulating an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US12005085B2 (en) 2013-12-20 2024-06-11 Seed Health, Inc. Probiotic method and composition for maintaining a healthy vaginal microbiome
CN103830145B (zh) * 2014-03-18 2015-10-28 林彤 一种含有生物肽与中药的牙膏
CN106488929B (zh) 2014-05-09 2021-08-24 乌得勒支大学控股有限公司 新型cath2衍生物
WO2016024296A2 (en) * 2014-08-14 2016-02-18 Council Of Scientific And Industrial Research Novel synthetic antimicrobial peptides
CN106674329B (zh) * 2015-11-05 2021-07-23 程家维 具备抗微生物、抗癌/促进伤口愈合活性的肽及其用途
WO2017134661A1 (en) * 2016-02-04 2017-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods for disrupting biofilms
CN107337713B (zh) * 2016-05-03 2022-05-13 上海医药工业研究院 一组抑菌肽及其制备方法
CN106390206B (zh) * 2016-08-17 2019-06-28 广州宏柯源生物科技有限公司 一种多肽水凝胶、其制备方法及应用
KR101899552B1 (ko) * 2016-11-18 2018-09-17 군산대학교 산학협력단 전복에서 유래한 항균 펩타이드 유사체 및 이를 포함하는 항균용 약학 조성물
US10111929B1 (en) * 2017-04-07 2018-10-30 Ez Ip, Llc Growth hormone releasing factor analogs and uses
CN109232719B (zh) * 2018-09-21 2021-06-29 中国科学院理化技术研究所 一种pH响应的抗菌肽及其制备方法和应用
US20220053773A1 (en) * 2018-10-01 2022-02-24 Innate Immunity LLC Compositions and methods for the treatment of pathogenic infections in plants
US20200102356A1 (en) * 2018-10-01 2020-04-02 NMC Inc. Compositions and Methods for the Treatment of Huanglongbing (HLB) aka Citrus Greening in Citrus Plants
KR102170236B1 (ko) * 2019-03-19 2020-10-29 (주)노바셀테크놀로지 신규 다중 기능성 펩타이드 및 그의 용도
US20220289794A1 (en) * 2019-08-29 2022-09-15 AJK Biopharmaceutical, LLC Synthetic antimicrobial peptides
US20230212235A1 (en) * 2019-12-30 2023-07-06 Ohio State Innovation Foundation Looped proteins comprising cell penetrating peptides
AU2021246017A1 (en) * 2020-03-31 2022-11-10 Innate Immunity LLC Recombinant peptide to treat fire blight
KR102220323B1 (ko) * 2020-05-15 2021-02-26 (주)노바셀테크놀로지 신규 다중 기능성 펩타이드 및 그의 용도
DE102020211387A1 (de) 2020-09-10 2022-03-10 Beiersdorf Aktiengesellschaft Wirkstoffhaltige Wundverschlusszubereitung
CN113248572B (zh) * 2021-04-30 2023-04-11 重庆理工大学 一种抗多重耐药菌环肽及其应用
WO2023029001A1 (zh) * 2021-09-03 2023-03-09 深圳千越生物科技有限公司 抗菌肽或肽衍生物、替换体以及其组合物、制备方法和应用
US20230134577A1 (en) * 2021-09-20 2023-05-04 The Procter & Gamble Company Jammed Emulsion Toothpaste Compositions Comprising Fluoride
WO2025217869A1 (en) * 2024-04-18 2025-10-23 Jiangsu Protelight Pharmaceutical & Biotechnology Co., Ltd. Antimicrobial peptides
US20250382332A1 (en) * 2024-06-12 2025-12-18 Invaio Sciences, Inc. Novel alpha-factor based peptides with antifungal activity
CN120289633B (zh) * 2025-02-27 2025-11-28 黄冈师范学院 抗变形链球菌的多肽、核酸分子及在制备抗变形链球菌的药物应用
CN120617172B (zh) * 2025-06-25 2026-03-24 中国科学院南海海洋研究所 一种安全无防腐剂的海龙抗菌肽喷雾剂及其制备方法和应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07501519A (ja) * 1991-09-13 1995-02-16 マゲイニン ファーマスーティカルズ,インコーポレーテッド 生物活性両親媒性ペプチド組成物およびその用途
AUPN861496A0 (en) * 1996-03-13 1996-04-04 Commonwealth Scientific And Industrial Research Organisation Lytic peptides
CA2294518A1 (en) * 1997-07-15 1999-01-28 Magainin Pharmaceuticals Inc. Biologically active peptides with reduced toxicity in animals and a method for preparing same
AU2683699A (en) * 1998-02-18 1999-09-06 Harbor-Ucla Research And Education Institute Antimicrobial peptides and derived metapeptides
US20040052814A1 (en) 1998-09-28 2004-03-18 Wenyuan Shi Fusion proteins for targeted delivery of antimicrobial peptides
US6610836B1 (en) * 1999-01-29 2003-08-26 Genome Therapeutics Corporation Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics
US20020068066A1 (en) 1999-08-20 2002-06-06 Wenyuan Shi Method for the treatment and prevention of dental caries
US20030143234A1 (en) 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
US7569542B2 (en) 1999-08-20 2009-08-04 The Regents Of The University Of California Anti-microbial targeting chimeric pharmaceutical
AU2001287178A1 (en) * 2000-08-15 2002-02-25 North Carolina State University Antimicrobial peptides isolated from mast cells
US6449760B1 (en) * 2000-11-30 2002-09-10 Lsi Logic Corporation Pin placement method for integrated circuits
US6875744B2 (en) * 2001-03-28 2005-04-05 Helix Biomedix, Inc. Short bioactive peptides
US7427408B2 (en) 2002-06-06 2008-09-23 The Regents Of The University Of California Quorum sensing and biofilm formation
US7087228B2 (en) * 2002-07-03 2006-08-08 University Of Southern California Preventing tooth decay and infective endocarditis using natural oligopeptides
US7671011B2 (en) * 2003-06-19 2010-03-02 Yeda Research & Development Co. Ltd. Antimicrobial and anticancer lipopeptides
US7875598B2 (en) 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
US7452856B2 (en) * 2004-07-06 2008-11-18 Seikagaku Corporation Antibacterial peptide
EP1793837A2 (en) 2004-09-27 2007-06-13 Technion Research & Development Foundation Limited Fatty acid modified polylysines as antimicrobial agents
PL1853620T3 (pl) * 2005-02-09 2012-07-31 Helix Biomedix Inc Heksapeptydy przeciwdrobnoustrojowe
ATE470857T1 (de) * 2005-04-05 2010-06-15 Allergan Inc Lipophile, farbstoffbasierte fret-assays für die clostridientoxinaktivität
WO2007005635A2 (en) * 2005-07-01 2007-01-11 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Mitotic spindle protein aspm as a diagnostic marker for neoplasia and uses therefor
CA2620935A1 (en) 2005-09-01 2007-03-08 The Regents Of The University Of California Method of using pore-forming peptides for genetic transformation, protein extraction, and transmembrane transport
AU2006294578B2 (en) * 2005-09-28 2013-02-07 The Regents Of The University Of California Calcium binding peptides
ES2497441T3 (es) * 2006-08-21 2014-09-22 The University Of British Columbia Péptidos inmunomoduladores catiónicos pequeños
CA2661634C (en) * 2006-09-06 2017-03-28 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
CN101622271B (zh) * 2007-01-16 2014-08-27 加利福尼亚大学董事会 抗微生物肽

Similar Documents

Publication Publication Date Title
AU2008251748B2 (en) Novel antimicrobial peptides
JP2004506693A5 (cg-RX-API-DMAC10.html)
CN102906105A (zh) 肽及其用途
RU2463308C2 (ru) Циклические противомикробные пептиды
TWI283684B (en) Analogues of GLP-1
Paquette et al. Inhibition of experimental gingivitis in beagle dogs with topical salivary histatins
CN108704119A (zh) 一种杀灭口腔致龋菌及抑制牙菌斑形成的抗菌肽及其应用
KR102500280B1 (ko) 치주질환 또는 탈구성 외상 치아의 예방 또는 치료용 약학 조성물
EP1313440A4 (en) DENTAL PREPARATIONS CONTAIN PEPTIDES THAT PROMOTE BONE GROWTH
JP2015509945A5 (cg-RX-API-DMAC10.html)
JP2020117504A5 (cg-RX-API-DMAC10.html)
US20250296961A1 (en) Antimicrobial peptides for remineralization of teeth and prevention of dental caries
CN112770740A (zh) 用于治疗和预防龈牙周炎或种植体周围炎的组合物以及涂覆有该组合物的牙间刷
RU2009131033A (ru) Природные полипептиды для ухода за полостью рта
EP2297195B9 (en) Antibacterial peptides
US20250275905A1 (en) Antibacterial and mineralizing compositions and methods of use thereof
US20200113818A1 (en) Dental strips for the delivery of specifically targeted antimicrobial peptides
EP3248591A1 (en) Method and product for caries treatment
CN101389642B (zh) 环状抗微生物肽
JPH06145033A (ja) ポビドンヨード含有歯磨組成物
WO2025088611A1 (en) Treatment and prevention of microbial infections in the oral cavity
EP3354320B1 (en) Composition for use in oral care and related apparatus for the treatment of the oral cavity
JPH05139943A (ja) 歯牙着色抑制用口腔用組成物
HK1121462B (en) Cyclic antimicrobial peptides